Hermetica Superfood Encyclopedia
The Short Answer
Dogonyaro contains azadirachtin, nimbolide, gedunin, and nimbin — limonoid terpenoids that disrupt parasite biochemistry, inhibit microbial membrane integrity, and modulate proinflammatory cytokine cascades. In rodent antimalarial models, aqueous leaf extract at 800 mg/kg achieved 79.6% chemosuppression of Plasmodium parasitemia, and n-hexane leaf fractions demonstrated 95% antibacterial activity with inhibition zones of 20–28 mm against Candida albicans in vitro.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keyworddogonyaro benefits
Dogonyaro — botanical close-up
Health Benefits
**Antimalarial Activity**
Azadirachtin and gedunin in leaf and bark extracts suppress Plasmodium parasitemia through chemosuppression and prophylactic mechanisms, achieving up to 79.6% and 75.3% parasite reduction respectively in murine models at 800 mg/kg.
**Antimicrobial and Antifungal Effects**
GC/MS analysis of n-hexane leaf extracts identified 45 bioactive compounds, 33 of which exhibit antifungal activity; methanol-miscible fractions demonstrated 95% antibacterial efficacy against multiple pathogens including Candida albicans with inhibition zones up to 28 mm.
**Antioxidant Protection**
Methanolic leaf extracts scavenge free radicals including DPPH, nitric oxide, superoxide, and hydroxyl radicals at IC50 ranges of 4.35–9.21 mg/ml, primarily through the action of phenolic compounds, quercetin, and nimbin reducing oxidative stress burden.
**Anti-inflammatory and Immunomodulation**
Neem extracts reduce the secretion of proinflammatory cytokines and elevate CD4+ and CD8+ T-lymphocyte counts, supporting adaptive immune responses; flower preparations in particular have been studied for immunostimulatory potential in preclinical models.
**Topical Skin Infection Treatment**: Neem oil's phenolic content
including hydroxy-tyrosol, caffeic acid, and ferulic acid — combined with its broad-spectrum antimicrobial activity makes it effective against dermatophytes and bacteria responsible for skin infections, supporting its traditional use for wound healing and dermatoses.
**Anticancer and Apoptotic Potential**
Nimbolide and azadirachtin modulate PI3K/Akt signaling pathways, reduce aberrant autophagy, and induce apoptosis in tumor cell lines in vitro, representing emerging but early-stage evidence for adjunctive oncological interest.
**Anti-diabetic and Hepatoprotective Effects**
β-sitosterol and quercetin in neem leaves inhibit alpha-glucosidase activity and reduce hepatic oxidative markers in animal studies, suggesting potential for glycemic regulation and liver protection, though human evidence remains absent.
Origin & History
Natural habitat
Azadirachta indica is native to the Indian subcontinent but has naturalized extensively across sub-Saharan Africa, particularly Nigeria and West Africa, where it is colloquially called Dogonyaro in Hausa. It thrives in tropical and subtropical semi-arid climates, tolerating poor soils, drought, and high temperatures, making it a resilient roadside and farmland tree across the Sahel belt. Cultivated for millennia in Ayurvedic traditions and now deeply integrated into African ethnomedicine, it is widely available as a spontaneously growing tree requiring minimal agricultural intervention.
“Azadirachta indica has been integral to Ayurvedic, Unani, and Siddha medicine systems for over 4,000 years, where it is revered as 'Sarva Roga Nivarini' — the curer of all ailments — referenced in ancient Sanskrit texts including the Charaka Samhita and Sushruta Samhita for treating skin diseases, fever, and infections. In sub-Saharan Africa, particularly among Hausa-speaking communities of northern Nigeria, the tree acquired the name Dogonyaro (meaning 'tall boy' or 'strong tree' in Hausa), and its leaves became a frontline household remedy for malaria, typhoid fever, and skin ulcers well before the arrival of synthetic pharmaceuticals. Traditional preparation in West Africa involves boiling fresh or dried leaves in water to produce a bitter decoction taken orally or used in medicinal baths for febrile illness and scabies, while bark scrapings are applied as poultices to infected wounds. The tree's cultural significance extends to ritual purification, agricultural pest control via azadirachtin-based biopesticides, and dental hygiene — neem twigs used as chewing sticks are documented in both African and South Asian ethnobotanical records spanning centuries.”Traditional Medicine
Scientific Research
The current evidence base for Dogonyaro (Azadirachta indica) is predominantly preclinical, consisting of in vitro assays and rodent model experiments, with no registered large-scale human randomized controlled trials identified in peer-reviewed literature to date. Murine antimalarial studies using Peters' 4-day suppressive test have quantified leaf extract efficacy at 79.6% parasitemia chemosuppression at 800 mg/kg and bark extract at 68.2%, though these doses are not directly translatable to human equivalents without allometric scaling and safety profiling. In vitro antimicrobial investigations using cup-plate diffusion methods and GC/MS-guided fractionation consistently demonstrate broad-spectrum activity, with methanol-miscible hexane fractions achieving 95% antibacterial activity, providing a mechanistic rationale for traditional use but insufficient for clinical dosing recommendations. The overall evidence quality is low-to-moderate by GRADE standards; the ingredient has substantial ethnopharmacological corroboration and mechanistically coherent laboratory data, but requires phase I/II human clinical trials before therapeutic claims can be validated.
Preparation & Dosage
Traditional preparation
**Leaf Decoction (Traditional)**
10–15 g of dried leaves boiled in 500 ml water for 15–20 minutes, consumed as a bitter tea once or twice daily for fever and malaria prophylaxis in West African traditional practice
**Bark Decoction**
10 g) simmered in water; used similarly for antimalarial and antipyretic purposes; preclinical chemosuppression data derived from aqueous extracts at 800 mg/kg in rodents
Bark chips (approximately .
**Standardized Leaf Extract (Capsule/Tablet)**
300–500 mg dry extract per dose
Commercial preparations typically standardized to 0.3–1% azadirachtin or total limonoid content; no universally accepted human clinical dose established; traditional dose equivalents suggest .
**Neem Oil (Topical)**
Cold-pressed seed oil applied directly to affected skin twice daily for fungal infections, dermatitis, and wound management; concentration of active phenolics varies by extraction method and seed source.
**Methanolic/Ethanolic Extracts (Research Grade)**
800 mg/kg (murine equivalent); human-equivalent dose extrapolation using body surface area conversion yields approximately 65–130 mg/kg, which has not been safety-tested in humans
Used in laboratory settings at .
**Timing Note**
Traditional antimalarial preparations are typically taken at onset of fever; prophylactic use is initiated days before anticipated exposure in endemic settings per ethnobotanical records.
Nutritional Profile
Fresh neem leaves contain ascorbic acid (vitamin C) at approximately 218 mg per 100 g dry weight, providing antioxidant micronutrient value alongside essential amino acids including glutamic acid, aspartic acid, and proline. The primary phytochemical load comprises over 300 identified compounds: limonoids (azadirachtin, nimbolide, gedunin, nimbin, nimbidin, salannin) concentrated in seeds and leaves; flavonoids (quercetin, kaempferol, rutin) contributing to antioxidant and anti-inflammatory capacity; and phenolic acids (caffeic acid, ferulic acid, hydroxy-tyrosol) predominant in neem oil. β-sitosterol, a phytosterol with cholesterol-modulating properties, is present in leaf and seed fractions. Bioavailability of limonoids is limited by poor aqueous solubility; lipid-based formulations (neem oil, ethanolic extracts) substantially improve absorption of azadirachtin and related terpenoids compared to plain aqueous decoctions, and the presence of dietary fats co-administered with extracts further enhances limonoid bioavailability.
How It Works
Mechanism of Action
Azadirachtin and nimbolide exert antimalarial and anticancer effects partly by disrupting PI3K/Akt intracellular signaling and reducing autophagy flux in target cells, while simultaneously inducing mitochondria-mediated apoptosis through cytochrome c release and caspase activation. Antimicrobial activity is attributed to the integration of limonoids and phenolic compounds into bacterial and fungal lipid bilayers, causing membrane depolarization, ion leakage, and protein efflux that are bactericidal and fungicidal. Anti-inflammatory actions involve downregulation of NF-κB-mediated transcription of proinflammatory cytokines such as TNF-α, IL-6, and IL-1β, while simultaneously supporting T-cell proliferation and elevating CD4+/CD8+ ratios indicative of enhanced cell-mediated immunity. Antioxidant effects are mediated by the electron-donating capacity of quercetin and hydroxylated phenolics, which quench reactive oxygen species including DPPH radicals, superoxide anion, and nitric oxide, thereby reducing lipid peroxidation at measurable IC50 values between 4.35 and 9.21 mg/ml in methanolic extract assays.
Clinical Evidence
No human clinical trials with defined sample sizes, randomization procedures, or statistically powered endpoints have been published for Dogonyaro as an isolated antimalarial or skin treatment intervention. The most quantitatively robust data originate from in vivo rodent experiments: leaf extract at 800 mg/kg achieved 79.6% chemosuppression versus chloroquine's 99.5%, and prophylactic reduction of 75.3% versus pyrimethamine's 98.3%, illustrating clinically meaningful but inferior efficacy compared to established antimalarials in animal models. In vitro studies provide consistent antibacterial and antifungal outcomes with inhibition zones of 20–28 mm, which meet classical breakpoints for antimicrobial significance but lack human pharmacokinetic and pharmacodynamic correlation. Confidence in translating these findings to human therapeutics remains low, and Dogonyaro should currently be classified as a promising ethnopharmacological lead compound rather than a clinically validated treatment.
Safety & Interactions
Dogonyaro is generally regarded as safe in traditional oral doses (leaf decoctions equivalent to 10–15 g dried leaf), with a long history of human use across Africa and South Asia without documented mass toxicity events; however, formal human safety pharmacology studies quantifying maximum tolerated doses, hepatotoxicity thresholds, or nephrotoxicity markers are absent from the published literature. High-dose neem oil ingestion — particularly in young children — has been associated with acute toxic encephalopathy and Reye's syndrome-like presentations in isolated case reports, and neem oil must not be administered orally to infants or young children. Drug interactions are mechanistically plausible: neem's immunomodulatory upregulation of CD4+/CD8+ T-cells may interfere with immunosuppressive therapy (e.g., corticosteroids, cyclosporine), and additive parasitemia suppression when combined with chloroquine or pyrimethamine raises the theoretical concern of potentiated side effects requiring monitoring. Pregnancy and lactation represent contraindications based on traditional knowledge of abortifacient and emmenagogue properties attributed to high-dose neem preparations, and use during these periods should be avoided until human safety data are established.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Azadirachta indicaNeemNimMargosaIndian LilacDongoyaroSarva Roga NivariniVeppu (Tamil)Limba (Yoruba)
Frequently Asked Questions
What is dogonyaro used for in traditional African medicine?
Dogonyaro (Azadirachta indica) is primarily used in West African traditional medicine for malaria treatment and prophylaxis, with leaf decoctions consumed during febrile episodes and as preventive teas in endemic seasons. It is also applied topically as a neem oil preparation or leaf poultice for bacterial and fungal skin infections, wounds, and scabies, and bark decoctions are used for typhoid fever and general systemic infections across northern Nigerian and Sahelian communities.
How effective is dogonyaro against malaria parasites?
In rodent Plasmodium models using Peters' 4-day suppressive test, aqueous leaf extract of Azadirachta indica at 800 mg/kg body weight achieved 79.6% chemosuppression of parasitemia and 75.3% prophylactic reduction, compared to the reference drug chloroquine at 99.5% and pyrimethamine at 98.3%. While these results demonstrate meaningful antiparasitic activity attributable to azadirachtin and gedunin, no equivalent human clinical trials exist, and dogonyaro should not replace WHO-approved antimalarial drugs for confirmed Plasmodium infections.
Is dogonyaro (neem) safe to take orally?
Oral consumption of neem leaf decoctions in traditional amounts (10–15 g dried leaves as tea) is generally considered safe based on centuries of widespread human use without documented population-level toxicity. However, neem oil must never be consumed orally — particularly by children — as ingestion has been linked in case reports to acute toxic encephalopathy, vomiting, and seizures; formal human toxicology studies establishing safe dose ceilings for standardized extracts are currently lacking in peer-reviewed literature.
What are the main bioactive compounds in dogonyaro and what do they do?
The principal bioactive compounds in Azadirachta indica are azadirachtin, nimbolide, gedunin, nimbin, and quercetin. Azadirachtin and gedunin suppress Plasmodium parasitemia and disrupt microbial membrane integrity; nimbolide modulates PI3K/Akt signaling pathways and induces apoptosis in cancer cell lines in vitro; nimbin contributes to radical scavenging and anti-inflammatory cytokine suppression; and quercetin acts as a polyphenolic antioxidant that quenches DPPH, superoxide, and hydroxyl radicals at IC50 values measured between 4.35 and 9.21 mg/ml in methanolic extract assays.
Can dogonyaro interact with malaria medications like chloroquine?
Preclinical evidence suggests that neem extracts may produce additive antiparasitic effects when used alongside chloroquine or pyrimethamine, as azadirachtin and gedunin operate through mechanisms distinct from quinoline-based drugs, potentially complementing their activity. This interaction is not yet characterized in human pharmacokinetic studies, and concurrent use without medical supervision carries the theoretical risk of amplified immunomodulatory effects or unpredictable pharmacodynamic outcomes; patients on antimalarial therapy should consult a qualified clinician before using dogonyaro preparations.
What is the difference between dogonyaro leaf extract and bark extract for antimalarial activity?
Both dogonyaro leaf and bark extracts contain antimalarial compounds like azadirachtin and gedunin, but they differ in potency and composition. Leaf extracts typically achieve around 79.6% parasite reduction in animal studies, while bark extracts reach approximately 75.3% reduction at equivalent doses of 800 mg/kg. The choice between them may depend on availability, traditional preparation methods, and whether prophylactic or chemosuppressive action is desired.
Is dogonyaro safe to use during pregnancy and while breastfeeding?
Traditional use of dogonyaro in African medicine during pregnancy is documented, but clinical safety data for pregnant and breastfeeding women is limited. Due to its potent bioactive compounds and historical use as a fertility regulator in some cultures, pregnant women should consult healthcare providers before supplementing. The lack of rigorous human studies in these populations warrants caution and professional medical guidance.
How do the antimicrobial and antifungal properties of dogonyaro compare to its antimalarial effects?
Dogonyaro leaf extracts contain 45 bioactive compounds identified through GC/MS analysis, with 33 demonstrating antimicrobial and antifungal properties alongside antimalarial activity. While the antimalarial compounds azadirachtin and gedunin are well-characterized, the broader spectrum antimicrobial and antifungal mechanisms are less thoroughly studied in clinical settings. This multifaceted activity suggests dogonyaro may offer broader protective benefits beyond malaria suppression, though more human research is needed to establish clinical efficacy for infections.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w dogonyaro-azadirachta-indica curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
